Apollomics (APLM) Other Non-Current Assets (2021 - 2025)
Apollomics (APLM) posted quarterly Other Non-Current Assets of $83000.0 for Q4 2025, up 10.67% year-on-year from $75000.0 in Q4 2024, and up 1.22% on a QoQ basis from $82000.0 in Q2 2025.
Apollomics (APLM) Other Non-Current Assets (2021 - 2025) Analysis & Trends
Apollomics (APLM) has reported Other Non-Current Assets for 5 consecutive years, with $83000.0 the latest figure, recorded in Q4 2025.
- Quarterly Other Non-Current Assets rose 10.67% year-over-year to $83000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $83000.0 (up 10.67% YoY) and the FY2025 annual result came in at $83000.0, up 10.67% from the prior year.
- Other Non-Current Assets rose to $83000.0 in Q4 2025 per APLM's latest filing, from $82000.0 in the prior quarter.
- Over the last five years, Other Non-Current Assets for APLM reached as high as $124000.0 in Q4 2022 and fell as low as $75000.0 in Q4 2024.
- A 5-year average of $103500.0 and a median of $113000.0 in 2021 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets sank 36.97% — and 2025, when it increased 10.67%.
- Year by year, Other Non-Current Assets stood at $113000.0 in 2021, then rose by 9.73% to $124000.0 in 2022, then slipped by 4.03% to $119000.0 in 2023, then plunged by 36.97% to $75000.0 in 2024, then grew by 10.67% to $83000.0 in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $83000.0, $82000.0, and $75000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Apollomics | 2.66 Bn | 2.66 Bn | - | 83,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 83,000.00 |
| Jun 30, 2025 | 82,000.00 |
| Dec 31, 2024 | 75,000.00 |
| Jun 30, 2024 | 113,000.00 |
| Dec 31, 2023 | 119,000.00 |
| Jun 30, 2023 | 119,000.00 |
| Dec 31, 2022 | 124,000.00 |
| Dec 31, 2021 | 113,000.00 |